Sign up


Match Document Document Title
8741605 Gene expression markers for breast cancer prognosis  
The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.
8741594 Mitochondrial enoyl coenzyme A hydratase 1 as marker for diagnosing stomach cancer  
The present invention relates to mitochondrial protein that can be used as a marker for diagnosing stomach cancer. According to the present invention, the marker for diagnosing stomach cancer...
8741587 ARMET as a marker for cancer  
Disclosed is a method aiding in the assessment of cancer. More specifically disclosed is the use of the arginine-rich metastasized in early tumors protein (=ARMET) as a universal marker of...
8741582 Detection of a specific DEK isoform as a urine-based biomarker for bladder cancer  
The present invention is directed to a method of detecting a DEK protein isoform 2 in a human urine sample using ELISA. Methods and compositions for detection of DEK isoform 2 in human urine are...
8741581 Markers for cancer detection  
The present invention relates to methods for detecting, prognosing and staging cancers, in particular cancers of the gastrointestinal tract. The methods of the invention comprise detecting specific...
8741574 Gene expression signature of genomic instability in breast cancer  
Methods of assessing genomic instability in breast cancer tissue by measuring the expression level of genes CDKN2A, SCYA18, STK15, NXF1, cDNA Dkfzp762M127, p28 KIAA0882, MYB, Human clone 23948,...
8741336 Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like  
Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, Alzheimer's disease, sleep...
8741288 Protein markers for detecting liver cancer and method for identifying the markers thereof  
The present invention relates to the diagnosis of liver cancer. It discloses the use of protein ERBB3 and protein IGFBP2 in the diagnosis of liver cancer. It relates to a method for diagnosis of...
8738124 Electrical bioimpedance analysis as a biomarker of breast density and/or breast cancer risk  
Methods and systems are provided for the noninvasive measurement of the subepithelial impedance of the breast and for assessing the risk that a substantially asymptomatic female patient will...
8737715 Methods and apparatus for diagnosis and/or prognosis of cancer  
The subject invention concerns methods for the detection, diagnosis, and/or prognosis of cancer by analyzing centrosomal features. In one embodiment, a method includes receiving an image of one or...
8735558 Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof  
This invention provides methods, processes, compounds and compositions for modulating the gene expression and modulating the secretion, expression, or synthesis of adhesion proteins or their...
8735439 Chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same  
The present invention relates to a novel chlorin e6-folic acid conjugate, a preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same, and more...
8735381 Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc  
The present invention relates to methods of administering compositions comprising a progesterone receptor antagonist for use in treating estrogen-dependent conditions. The invention is also...
8735365 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy  
Provided is a method of treating cancer in a subject by inhibiting expression of PAX2. An example of a cancer treated by the present method is prostate cancer. In the cancer treatment methods...
8735358 Methods for treating cancer by regulation of tumor necrosis factor-alpha  
The present invention relates to compositions and methods relating to an interleukin18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In...
8735342 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor  
The present invention is directed to methods of using HSS1 (Hematopoietic Signal peptide-containing Secreted 1), HSM1 (Hematopoietic Signal peptide-containing Membrane domain-containing 1), or a...
8735078 Apolipoprotein AII assay method for the in vitro diagnosis of colorectal cancer  
The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Apolipoprotein AII tumor marker in a biological sample taken from a...
8735076 Targets for use in diagnosis, prognosis and therapy of cancer  
Provided herein are targets that can be used for the diagnosis, prognosis and therapy of a variety of cancers.
8735075 Cancer screening by detection of ultrastructural and molecular markers  
The present invention relates to detection of cancer, or assessment of risk of development thereof. In particular, the present invention provides compositions and methods detection of field...
8735061 Biomarkers of cancer metastasis  
There is provided a method for determining tumour metastatic potential using biomarkers of tumour metastasis comprising any two of carbonic anhydrase-9 (CAIX), vascular endothelial growth factor C...
8734863 Bioactive fraction of Petiveria alliacea, pharmaceutical composition containing same, and combination with immunostimulants for treating cancer  
The invention relates to a bioactive fraction of Petiveria alliacea having an antitumour activity, and to the use of same for producing medicaments for treating cancer. The invention also relates...
8734859 Molecular combinations for cancer or other disease treatment  
A method and medicine for treating leukemia or other cancer or disease condition including administering periodic doses of a combination of one or more of emodin, rhein or rhapontin with one or...
8734799 Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer  
Disclosed herein are methods and compositions for treating cancer. In particular, the in vivo efficacy of unconjugated anti-TfR antibodies, such as ch128.1, are disclosed herein.
8731839 Method and system for robust classification strategy for cancer detection from mass spectrometry data  
A robust classification method for cancer detection from mass spectrometry data includes inputting the mass spectrometry data, preprocessing the spectrometry data, conducting robust feature...
8729270 Anti-cancer compounds, synthesis thereof, and methods of using same  
Embodiments relate to the field of chemistry and biochemistry, and, more specifically, to anti-cancer compounds, synthesis thereof, and methods of using same. Disclosed herein are various...
8729226 Cancer therapy method  
This invention describes a method for treating cancer by increasing the nuclear localization of the COMMD1 protein, which is associated with decreasing or blocking the proliferation of the cancer...
8729133 Method for treating cancer  
This invention relates to a process of treating/affecting cancers that are particularly susceptible to radiation therapy by administering to a host in need of such treatment an amino acid and...
8729080 Cancer therapy  
The subject invention provides for cancer therapy.
8728823 Methods for detecting lung cancer and monitoring treatment response  
A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer....
8728744 Salivary protein biomarkers for human oral cancer  
The present invention relates to the identification of novel oral cancer and periodontal disease biomarkers. Further, the present invention provides novel methods of diagnosing and for providing a...
8728739 RBM3 in colorectal cancer prognostics  
The present invention provides means, such as a method, for determining whether a mammalian subject having a colorectal cancer belongs to a first or a second group, wherein the prognosis of...
8728732 Global DNA hypomethylation and biomarkers for clinical indications in cancer  
The present invention provides methods of determination of a global DNA methylation index (GDMI) in a sample from a subject, using a variety of methods which can detect global, genome-wide, and...
8728546 Medicament for treatment of cancer, cardiovascular diseases and inflammation  
The invention provides a medicament for the treatment of cancer, cardiovascular diseases and/or inflammation. The medicament may be administered orally, parenterally or topically.
8728468 Treatments for cancer  
The present invention provides methods for reducing tumor survival, expansion, and metastasis. In particular, the invention provides methods for reducing melanoma tumor survival, expansion, and...
8725426 Gene expression profile algorithm and test for determining prognosis of prostate cancer  
The present invention provides algorithm-based molecular assays that involve measurement of expression levels of genes, or their co-expressed genes, from a biological sample obtained from a...
8722964 Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes  
This invention relates to the engineering of animal cells, preferably mammalian, more preferably rat, that are deficient due to the disruption of tumor suppressor gene(s) or gene product(s). In...
8722897 Metal complexes of thiourea and derivatives as metal delivering anti-cancer and anti-inflammatory agents  
The present invention relates to metal thiourea complexes comprising N-substituted thiourea ligands and sulfur-coordinated metal ions, and methods for using the metal thiourea complexes for...
8722367 Detecting PAX2 for the diagnosis of breast cancer  
A method for monitoring breast conditions in a subject is disclosed. The method comprises determining a Paired Box 2 gene-to-beta defensin-1 gene (PAX2-to-DEFB1) expression ratio (the “Donald P...
8722340 JAB1 as a prognostic marker and a therapeutic target for human cancer  
Methods of diagnosing and prognosticating the development of human cancers, such as breast cancer, colon cancer, and pancreatic cancer, are provided. The diagnostic and prognostic methods include...
8722331 Method for selecting a treatment for non-small cell lung cancer using gene expression profiles  
The present invention identifies and quantifies changes in gene expression associated with non-small cell lung cancer NSCLC by examining gene expression in tissue from normal lung and diseased...
8722325 Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer  
The present invention relates to the discovery that, in human cancer, an 11q deletion of ATM together with an increase in ATR and CHEK1 expression correlates with resistance to ionizing radiation...
8722088 Pharmaceutical compositions and methods for the treatment of prostate cancer  
Compositions, kits, and methods are provided directed to the treatment of prostate cancer using a maintenance dose of degarelix or pharmaceutically acceptable salt thereof, an excipient, and a...
8722050 Method of treating virus-induced cancer  
The present invention relates to methods of treating virus-induced cancer with the polypeptides that are capable of killing cells. The polypeptide comprises a targeting agent covalently attached to...
8718996 Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents  
A testing method for identification whether a cancer patient is a member of a group or class of cancer patients that are not likely to benefit from administration of a platinum-based chemotherapy...
8718231 X-ray tomography method and apparatus used in conjunction with a charged particle cancer therapy system  
The invention comprises an X-ray tomography method and apparatus used in conjunction with multi-axis charged particle or proton beam radiation therapy of cancerous tumors. In various embodiments,...
8716355 Hydroxylated tolans and related compounds in the treatment of a cancer  
Compounds of the hydroxytolan family kill tumor cells, inhibit tumor growth and development, and are thus useful in method for treating a tumor or cancer in subjects in need thereof. These...
8716346 Alkylating agent combinations in the treatment of cancer  
This application provides compositions and methods useful in the treatment of certain cancers. In part, this application is based on the recognition that certain molecules that target abasic...
8716328 Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents  
The present application discloses an acid labile lipophilic molecular conjugate of cancer chemotherapeutic agents and methods for reducing or substantially eliminating the side effects of...
8716299 XIAP-targeted prostate cancer therapy  
A treatment for prostate cancer using cyclin-dependent kinase inhibitors is provided. The effects of cyclin-dependent kinase inhibitors on the survival of prostate cancer cells was examined....
8716297 Chemical entities to be used for Wee1 inhibition for the treatment of cancer  
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, A, B, and n are defined in the description. The present invention relates also to...